Jacqueline Clavel MD, PhD epidemiology
Course and current status
Experience and responsibilities
2015-… Leader of the Inserm team « Epidemiology of cancers of children and adolescents » (EPICEA) of the Research center of epidemiology and statistics of Paris-Sorbonne-Cité (CRESS), INSERM U1153 (Dir. P. Ravaud)
2011-… Direction of the infrastructure (Investment for the future) HOPE-EPI - Childhood Cancer Observation Platform
2010-2014 Leader of the Inserm team « Environmental epidemiology of cancers » of the Research center of epidemiology and population health (CESP), INSERM U1018 (Dir. D. Hémon)
2006-2009 Director of the research unit « Environmental epidemiology of cancers », INSERM UMR-S754
1999- … Co-creation of the National registry of childhood solid tumors
1994- … Creation and direction of the National registry of childhood hematopoietic malignancies (retroactive 1990-…)
1991- … Permanent position at Inserm (1991-CR2, 1995-CR1, 2000-DR2, 2009-DR1)
1985-1988 Paris hospital and university assistant in physiology (Broussais/UPMC)
1984-1985 Paris hospital and university assistant in physiology (Necker/Paris Descartes)
Qualifications
1995 PhD in Epidemiology, Paris-Sud University
1988 Master of Biostatistics and Health, Paris-Sud University
1981 Doctor in Medicine, Paris Descartes University, Necker Faculty
Scientific boards
2023-... Scientific committee of Permanent access to SNDS data Inserm
2022-... Scientific committee of Health of women and children after ART, Agence de la Biomédecine
2022-... Scientific board of GEOCANCER, Cancéropôle Ile-de-France
2019-... Steering committee of REALYSA
2018-2021 Scientific council of the International Agency for Research on Cancer - French member
2015-2017 Scientific board on phytopharmacovigilance (ANSES)
2014-2015 Scientific board of the National public health institute (InVS)
2013-2022 Scientific board of Paris medical research Emergence
2013-… Scientific board of National multi-organization institute (ITMO) cancer of AVIESAN
2011-2015 Scientific board of French school of public health (EHESP)
2011 Working group on Epidemiological surveillance around a disposal of high-level radioactive waste (ANDRA)
2010-2014 Steering Committee of the Cancéropôle Ile-de-France
2009 Expert group on health and EMF-ELF (ANSES)
2008-2013 Scientific board of the Doctoral School Paris Sud-Paris -Descartes
2008-2012 Working group on Leukemia and nuclear sites (ASN)
2008-2009 National Committee of Rare Diseases Registries
2008-… Management group of the Childhood leukemia international consortium CLIC
2007-2011 Education council of French school of public health (EHESP)
2007 Evaluation committee of Canceropoles (INCa)
2006-… Working group Cancer of the ELFE birth cohort
2006-2011 Evaluation commission #5 of ARC
2006-2008 Expert group cancer and environment (INSERM)
2004-2011 Scientific board of SFCE (French Society of Childhood Cancer)
2004-2005 Expert group cancer and environment – methods (INSERM)
2004 Working group on rare diseases (DGS)
2003-2007 Member of the scientific specialized commission CSS3 of Inserm
2003-2006 Expert group on Hepatitis B vaccination and childhood leukemia (ANSM)
2003-2004 European working group « Childhood cancer and environment » (SCALE)
2002-2005 Expert group on health and EMF-ELF (DGS) "Champs électriques et magnétiques à basse fréquence" (DGS)
2002-2004 Working group on Analysis of space-time clusters (InVS)
2001-2007 Coordination of expertise and investigation of a cluster of childhood cancers in a school at Vincennes (InVS)
2000 Expert group on Surveillance of risks related to ionizing radiation (InVS)
1997-1998 Expert group on Surveillance of risks related to ionizing radiation (RNSP)
Societies and scientific groups
Member of the SFCE, SIOPE, SIOP, PANCARE, ENCR, IACR – Member of CLIC international consortium, CONCORD Group
Scientific summary
Jacqueline Clavel, MD, PhD is research professor at Inserm and has devoted most of her research to the development of epidemiological research on childhood cancers. One of her main areas of research aims to improve knowledge of childhood cancer risk factors, and has contributed to document the role of environmental, genetic, perinatal and lifestyle risk factors. A growing part of her research is devoted to the long-term epidemiological follow-up of childhood cancer survivors. The development of infrastructures capable of providing standardized and quality-controlled information on a national and comprehensive basis has been crucial to this area of research. With her team, she created the National registry of childhood cancer and then the Childhood Cancer Observation Platform, which complements the registry with several databases, in particular the national COHOPER cohort of all patients diagnosed since 2000. The field can now rely on invaluable data from tens of thousands of children.
